Navigation Links
Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection
Date:4/22/2013

ay any decision past the time frames anticipated by us, limit any approved indications, or deny the approval of VP20621. There can be no assurance that we will be successful in finding a partner to complete the development and commercialization of VP20621. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K for the year ended December 31, 2012 and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2013, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements. These forward looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this press release.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014 Using publicly released ... health plan costs for five common specialty drugs. ... consumers given their high costs and shortage of ... cost thousands per prescription, and are used for ... and multiple sclerosis. HealthPocket found ...
(Date:8/26/2014)... 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and its associated ... to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 ... affects more than 100,000 Americans. As this disease ... gradually lose the ability to breathe, leading ultimately ...
(Date:8/26/2014)... NEW YORK and LONDON ...   FDNA Inc. ( http://www.fdna.com ) ... today that they have partnered to offer, for the ... exclusively through FDNA,s solutions. FDNA, developer of ... fully integrate LMD,s award-winning collection into Face2Gene [ ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
... ATLANTA, June 7, 2011 CardioMEMS, Inc ., an ... a proprietary wireless sensing and communication technology for the human ... Yadav, M.D. , is a finalist for the 25th annual ... Entrepreneur category. The awards are sponsored by the Metro Atlanta ...
... June 7, 2011 The ALS Therapy Development Institute ... Michael Capuano (D-MA) with its first ever "Lou Gehrig ... gala event this November 3rd.  The award recognizes ... advocate for additional funding for research leading to an ...
Cached Medicine Technology:Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 2Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 3U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS TDI During Gala Event this November 2
(Date:8/27/2014)... 2014 PCOS (Polycystic Ovarian Syndrome) affects ... at risk for a number of health disorders and ... well understood even within the medical community. Many women ... (hirsutism) and excess body fat around the waist area ... problems are caused by PCOS. , Awareness is the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... PartnerTech AB, a major systems integration and electronics ... Cryotherapy offering the first U.S. designed and ... offered the ideal combination of manufacturing expertise, location, ... system. Impact Cryotherapy, headquartered in Atlanta, GA, offers ...
(Date:8/27/2014)... DeLand, FL (PRWEB) August 27, 2014 *Anyone who ... in DeLand, FL can visit Avail Clinical Research on the web ... Fibromyalgia , Over 5 million Americans are affected by fibromyalgia – ... such as:, Chronic widespread pain , ... Chronic fatigue and sleep problems , Depression , ...
(Date:8/26/2014)... Co (PRWEB) August 27, 2014 Carol ... new cookbook— 100 Best Quick Gluten-Free Recipes (Houghton ... gluten-free meals. , Fenster believes that cooking gluten-free ... understands how today’s busy lifestyle doesn’t leave much time ... that gluten-free cooks ask me is how to shorten ...
(Date:8/26/2014)... Wauwatosa, WI (PRWEB) August 27, 2014 AlignLife ... the month of July. "We had a goal to collect ... Force", Dr. Sara Mahalko said. "Our patients helped us not ... our goal." AlignLife of Wauwatosa collected 559lbs of ... the bar high for next year," explains Dr. Katie Sam. ...
Breaking Medicine News(10 mins):Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 2Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 3Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 2Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 3Health News:AlignLife Wauwatosa Thanksgiving in July Yields over 500 lbs of Food 2
... that are commonly referred to as non-communicable diseases could cause ... of the health care cost by 2015, according to estimates ... million people in 2005 to NCD, the toll might reach ... Robert Beaglehole, director of NCD, WHO. ,He was ...
... Pradesh, 136 have been found to be due to ... announced this shocking report in the Assembly. ... identify individuals/health organizations involved in the controversial blood transfusion ... would be implemented to avoid such instances in the ...
... Birth under the Guangdong Family Planning Research Institute in ... discovered 39 cases of new abnormal chromosomes. // ... scientists for genetic and cloning researches. ,Director ... these cases of abnormal chromosomes have been verified by ...
... AIDS/HIV, which is haunting the world for over two decades ... countries in the Asia Pacific // Region would meet in ... treatment and prevention would be the main focus of the ... target to expand AIDS treatment to over 3 million universal ...
... the second leading cause of blindness, worldwide would affect 60 ... end of 2020, // based on a projection in the ... and Africa would be the worst affected by the disabling ... of all glaucoma cases by then. Six out of ...
... treat pneumonia, bronchitis and other infections. Bristol-Myers Squibb Co. ... U.S. Food and Drug Administration said that the drug ... from blood-sugar changes due to this drug. ... of serious cases of hypoglycemia (low blood sugar) and ...
Cached Medicine News:
Athouritative, on the spot answers for acute care and consultations....
The workhorse electric system....
... Knife with BD Xstar Blade includes a ... the blade in prodedure and handling. ... a grind-less process for manufacturing surgical blades. ... and consistency. The arch style, single-bevel ...
... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...
Medicine Products: